Change in Rx Label Design Has No Effect on Patient Medication Use, Safety or Health

    • September 30, 2009

Researchers at Brigham and Women's Hospital in Boston conducted a study to see if an improved label design for prescription drugs—launched nationwide by Target Corp. in May 2005—influenced patients' adherence to essential medications, safety and health outcomes for specific chronic diseases.

Study results were published in and reported by peer-reviewed journals.

Key Findings

  • Investigators found no statistically significant effect from the labeling intervention on any of the measured outcomes: medication adherence, outpatient physician or emergency room visits, or hospitalizations for patients with chronic diseases.